Further Characterization of Growth Hormone-Dependent Somatomedin-Binding Proteins in Rat Serum and Demonstration of Somatomedin-Binding Proteins Produced by Rat Liver Cells in Culture*
- 1 February 1979
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 104 (2), 536-546
- https://doi.org/10.1210/endo-104-2-536
Abstract
The somatomedin-like peptide multiplicationstimulating activity (MSA) binds specifically to rat serum. The pattern of MSA binding is GH dependent. Specific binding of [l25I]iodo-MSA in normal rat serum is primarily in the y-globulin region (peak II) on Sephadex G-200, while MSA binding in hypophysectomized (hypox) rat serum is near the albumin region (peak III). This study further characterizes the peak II and peak III somatomedin-binding proteins in rat serum and compares them with somatomedin-binding proteins produced by rat liver cells in culture. [l25I]Iodo-MSA binding to normal rat serum is abolished by trypsin pretreatment of rat serum, suggesting that MSA binds to protein components of serum. The only detectable somatomedin activity (measured by [3H]thymidine incorporation into chick embryo fibroblast DNA) in fractions of normal rat serum chromatographed on Sephadex G-200 coincides with peak II binding of [125I]iodo-MSA. In hypox rat serum, the majority of detectable somatomedin activity is in the peak III region. There is complete displacement of the human somatomedins [l25I]iodoinsulin-like growth factor I and II and [l2r>I]iodosomatomedin A from the rat serum-binding sites by unlabeled MSA, suggesting that the human somatomedins bind to the same sites as MSA. Treatment of normal rat serum with 1 M acetic acid dissociates somatomedin activity from its binding proteins and converts somatomedin-binding proteins from peak II to peak III. Scatchard analysis of competitive binding data using [125I]iodo- MSA yields a binding affinity that is not appreciably different for either normal or hypox rat sera. The binding capacity of normal or acid-treated normal rat serum for MSA is significantly greater than that for comparably treated hypox rat sera. Although the site of synthesis of somatomedin-binding proteins in vivo is unknown, specific somatomedin-binding proteins are synthesized by two rat liver cell lines in culture. These rat liver cell somatomedin-binding proteins have the same molecular size and the same binding affinity for MSA as the peak III somatomedinbinding protein (s) in rat serum.Keywords
This publication has 11 references indexed in Scilit:
- Demonstration of Specific Plasma Protein Binding Sites For SomatomedinJournal of Clinical Endocrinology & Metabolism, 1977
- A Growth Hormone Binding Factor in the Serum of Pregnant MiceEndocrinology, 1977
- Proliferation of buffalo rat liver cells in serum-free medium does not depend upon multiplication-stimulating activity (MSA)Cell, 1977
- Identification of a Receptor for Somatomedin-Like Polypeptides in Human Fibroblasts*Journal of Clinical Endocrinology & Metabolism, 1977
- Demonstration of a Specific Serum Carrier Protein of Nonsuppressible Insulin-like Activity in Vivo*Journal of Clinical Endocrinology & Metabolism, 1977
- Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.Proceedings of the National Academy of Sciences, 1976
- Size Heterogeneity of Human Serum Somatomedin12Journal of Clinical Endocrinology & Metabolism, 1976
- THE SERUM HALF-LIFE OF SOMATOMEDIN ACTIVITY: EVIDENCE FOR GROWTH HORMONE DEPENDENCEActa Endocrinologica, 1976
- Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.Proceedings of the National Academy of Sciences, 1976
- The Effects of Insulin and Growth Hormone on the Release of Somatomedin by the Isolated Rat LiverEndocrinology, 1976